News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Yüksel Ürün: Bias Risk in Studies Comparing Trimodal Therapy and Radical Cystectomy
Yüksel Ürün/X
Jun 22, 2025, 05:46

Yüksel Ürün: Bias Risk in Studies Comparing Trimodal Therapy and Radical Cystectomy

Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X about a paper by Daniele Robesti et al. published in Critical Reviews in Oncology/Hematology:

“Most retrospective studies comparing trimodal therapy and radical cystectomy are at high risk of informative censoring a bias that can artificially favor one treatment over another.”

Title: Trimodal Treatment vs Radical Cystectomy for Muscle-invasive Bladder Cancer: the Neglected Impact of Informative Censoring. A Systematic Review and Meta-analysis

Authors: Daniele Robesti, Filippo Micheli, Shesh N Rai, Giuseppe Fallara, Andrea Gallina, Francesco Montorsi, Alberto Briganti, Nicola Fossati, Antoine G van der Heijden, Guillaume Ploussard, Bernard Malavaud, Alberto Martini

Yüksel Ürün: Bias Risk in Studies Comparing Trimodal Therapy and Radical Cystectomy

You can read the Full Article in Critical Reviews in Oncology/Hematology.

More posts featuring Yüksel Ürün.

Alberto Briganti Alberto Martini Andrea Gallina Antoine G. Van der Heijden Bernard Malavaud bladder cancer cancer Daniele Robesti Filippo Micheli Francesco Montorsi Giuseppe Fallara Guillaume Ploussard MIBC Nicola Fossati OncoDaily Oncology radical cystectomy Shesh N Rai Trimodal Treatment Yüksel Ürün
Special Coverage
Drugs
Jul 10, 2025, 04:47
Taletrectinib (Ibtrozi) 2025 Updates: Uses in Cancer, Side effects, Dosage, Expectations and more
Oncolibrary
Jul 10, 2025, 04:47
Hormonal Therapy in Cancer: Mechanisms, Resistance and Clinical Applications in Breast and Prostate Cancer
Drugs
Jul 10, 2025, 01:19
Cisplatin in Cancer Treatment: Mechanism, Resistance, Toxicity, and Future Directions
Blog
Jul 9, 2025, 23:49
Sami Mansfield: Jumpstart July - Education plus Empowerment for Menopause After Cancer 
Insight
Jul 9, 2025, 23:06
Steven Rosenberg: The beginning of a new way to use immunotherapy
Blog
Jul 9, 2025, 22:10
Roland Busch: The busier the schedule, the more important the workout and discipline becomes
Blog
Jul 9, 2025, 21:45
Pierre Foidart: Honored to Receive Clinical Research Mandate from Stichting tegen Kanker - Fondation contre le Cancer
Blog
Jul 9, 2025, 21:20
Herbert Loong: Sarcomas Are a Group of Rare Diseases Which Benefits From Awareness and Specialist Care
Blog
Jul 9, 2025, 21:13
Asfand Yar Cheema: Calling All Internal Medicine Residents
Opinion
Jul 9, 2025, 21:08
Paolo Tarantino Opens the 3rd Annual ADC Toxicity Summit
Insight
Jul 9, 2025, 21:02
Marianna Vitaloni: I'm Incredibly Grateful to the Patients Who Shared Their Stories With Us
Blog
Jul 9, 2025, 20:28
Jennifer Guida: I Had the Privilege to Lead Pioneering Work at the NCI Focused on Cancer Survivorship, Healthy Aging, and Resilience